Lubrizol Life Science Health opens $60M commercial manufacturing facility in Bethlehem, Pennsylvania

Lubrizol's CDMO, now renamed Lubrizol Life Science Health (LLS Health), opened a new 5,000 sq. ft commercial manufacturing facility in Bethlehem, Pa., as part of a $60 million investment.

“LLS Health announced its expanded commercial-scale capabilities for drug product manufacturing with the opening of its new 5,000 sq. ft commercial manufacturing facility in Bethlehem, Pa., as part of a $60 million investment.”globenewswire.com

• 1 source
• globenewswire.comParticle Sciences becomes Lubrizol Life Science HealthLubrizolNov 5, 2019

Summarized from public sources; check the original articles before acting on it.